The deal gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication Ohtuvayre.

Merck is expanding its pipeline and portfolio of cardio-pulmonary disease treatments by acquiring Verona Pharma plc.

RAHWAY, N.J. - The U.S. Food and Drug Administration has accepted and granted priority review for Merck’s (NYSE:MRK) supplemental application seeking to update the label for WINREVAIR based on ...

RAHWAY, N.J., June 12, 2025--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced ...

RAHWAY, N.J. - Pharmaceutical giant Merck (NYSE:MRK), with a market capitalization of $203 billion and impressive 77% gross profit margin, will present new data from its HIV research pipeline at ...

Media: Kim Gorode 973-255-8094 [email protected] Investor: Peter Dannenbaum 908-740-1037 [email protected] ...

Editor’s note: This story was updated at 8:47 a.m. June 19, 2025, to note that Merck Manuals – a separate entity from Merck – launched the new tool.

RAHWAY, N.J., June 12, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the MOBILIZE-1 Phase 3 clinical trial evaluating the safety ...

Merck Animal Health Receives EU CVMP Positive Opinion for NUMELVI™ (atinvicitinib) Tablets for Dogs Jun. 12, 2025 4:45 PM ET Merck & Co., Inc. (MRK) ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 3 HYPERION study evaluating ...

Merck's U.S. headquarters are in Rahway, New Jersey. When asked whether the company had plans to reduce its workforce at any of its other sites in Pennsylvania, Merck released a statement that ...